login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
UNITED THERAPEUTICS CORP (UTHR) Stock News
USA
- NASDAQ:UTHR -
US91307C1027
-
Common Stock
438.18
USD
+18.97 (+4.53%)
Last: 10/1/2025, 9:38:01 PM
438.18
USD
0 (0%)
After Hours:
10/1/2025, 9:38:01 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
UTHR Latest News, Press Relases and Analysis
All
Press Releases
15 days ago - By: Chartmill
United Therapeutics Corp (NASDAQ:UTHR) Emerges as a Top Peter Lynch-Style GARP Investment
16 hours ago - By: Zacks Investment Research
- Mentions:
INSM
LQDA
Is IPF the Next Big Market Opportunity for United Therapeutics?
18 hours ago - By: Zacks Investment Research
- Mentions:
AMGN
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
a day ago - By: Zacks Investment Research
- Mentions:
USB
APD
NEE
NI
...
Top Stock Reports for NextEra Energy, U.S. Bancorp and Air Products & Chemicals
6 days ago - By: Benzinga
- Mentions:
FHN
VMI
LYEL
SYRE
This United Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday
13 days ago - By: United Therapeutics Corporation
United Therapeutics Corporation to Review Data from the Successful TETON-2 Pivotal Study of Nebulized Tyvaso® in Idiopathic Pulmonary Fibrosis
16 days ago - By: United Therapeutics Corporation
United Therapeutics Corporation to Present at the Bernstein 2nd Annual Healthcare Forum
20 days ago - By: United Therapeutics Corporation
United Therapeutics to Feature Clinical Data Across its Commercial and Development Portfolio at the European Respiratory Society Congress
22 days ago - By: Investor's Business Daily
- Mentions:
AUPH
HALO
ARGX
United Therapeutics Price Strength Rating Jumps After Its Stock Soared 33% Last Week On Positive Drug Test Results
25 days ago - By: Benzinga
- Mentions:
IOT
CIEN
EXAS
SATS
...
Wayfair, United Therapeutics, And Ciena Are Among The Top 10 Large-Cap Gainers Last Week (July 14-July 18): Are The Others In Your Portfolio?
a month ago - By: Zacks Investment Research
- Mentions:
INSM
LQDA
UTHR Stock Hits Record High on Tyvaso Meeting IPF Study Goals
a month ago - By: Yahoo Finance
- Mentions:
DB
PEP
STZ
SIG
...
Morning Movers: United Therapeutics surges after TETON-2 met primary endpoint
a month ago - By: Stocktwits
- Mentions:
MNKD
MannKind Lands A Price-Target Hike After Partner United Therapeutics Reports Strong Lung Drug Trial Results
a month ago - By: Stocktwits
- Mentions:
AVUS
DRUP
This Pharma Stock Soared 36% Today And Drew Price Target Hikes From Wall Street – More Details Inside
a month ago - By: Investor's Business Daily
- Mentions:
INSM
LQDA
Why United Therapeutics Just Catapulted 35%, Pulling Insmed, Liquidia With It
a month ago - By: United Therapeutics Corporation
United Therapeutics Corporation Announces TETON-2 Pivotal Study of Tyvaso® Meets Primary Endpoint for the Treatment of Idiopathic Pulmonary Fibrosis
a month ago - By: Zacks Investment Research
Why Is United Therapeutics (UTHR) Up 11.9% Since Last Earnings Report?
a month ago - By: United Therapeutics Corporation
United Therapeutics Corporation to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference
a month ago - By: Stocktwits
- Mentions:
MNKD
MannKind, United Therapeutics Expand Agreement To Develop A Second Investigational Molecule Together
Please enable JavaScript to continue using this application.